2023
DOI: 10.1158/1535-7163.22518843
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Supplementary Data from Preclinical Development of MGC018, a Duocarmycin-based Antibody–drug Conjugate Targeting B7-H3 for Solid Cancer

Abstract: <p>Supplementary Data</p>

Help me understand this report
View published versions

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles